Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.

Thomas SS, Makar KW, Li L, Zheng Y, Yang P, Levy L, Rudolph RY, Lampe PD, Yan M, Markowitz SD, Bigler J, Lampe JW, Potter JD.

Genom Data. 2015 Sep 1;6:154-8. doi: 10.1016/j.gdata.2015.08.029. eCollection 2015 Dec.

2.

Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc.

Adams SV, Barrick B, Christopher EP, Shafer MM, Makar KW, Song X, Lampe JW, Vilchis H, Ulery A, Newcomb PA.

Toxicol Appl Pharmacol. 2015 Dec 15;289(3):381-8. doi: 10.1016/j.taap.2015.10.024. Epub 2015 Oct 31.

3.

Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U.

Nat Commun. 2015 Oct 26;6:8739. doi: 10.1038/ncomms9739. No abstract available.

PMID:
26498495
4.

MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles.

Yu M, Carter KT, Makar KW, Vickers K, Ulrich CM, Schoen RE, Brenner D, Markowitz SD, Grady WM.

Epigenetics. 2015;10(9):803-9. doi: 10.1080/15592294.2015.1068490. Epub 2015 Jul 17.

5.

Genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucc EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U.

Nat Commun. 2015 Jul 7;6:7138. doi: 10.1038/ncomms8138. Erratum in: Nat Commun. 2015;6:8739. Kury, Sebastian; Giocannucci, Edward L. and Lemire, Mathiew [Corrected to Küry, Sébastien; Giovannucci, Edward L. and Lemire, Mathieu].

6.

Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study.

Cheng TY, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SA, Zheng Y, Poole EM, Galbraith RL, Duggan DJ, Habermann N, Bailey LB, Maneval DR, Caudill MA, Toriola AT, Green R, Ulrich CM.

Cancer. 2015 Oct 15;121(20):3684-91. doi: 10.1002/cncr.29465. Epub 2015 Jun 24.

7.

Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.

Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1229-38. doi: 10.1158/1055-9965.EPI-15-0094. Epub 2015 Jun 2.

8.

Response to "Civil time ≠ biological time: Recent options for empirically testing possible effects of chronodisruption".

Bhatti P, Adams C, Zhang Y, Song X, Makar KW, Sather CL, Kelsey KT, Houseman EA, Wang P.

Chronobiol Int. 2015 Jun;32(5):699-700. doi: 10.3109/07420528.2015.1039887. Epub 2015 May 18. No abstract available.

PMID:
25980781
9.

Prediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics.

Hardikar S, Newcomb PA, Campbell PT, Win AK, Lindor NM, Buchanan DD, Makar KW, Jenkins MA, Potter JD, Phipps AI.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1130-7. doi: 10.1158/1055-9965.EPI-15-0039. Epub 2015 May 14.

10.

Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.

Thomas SS, Makar KW, Li L, Zheng Y, Yang P, Levy L, Rudolph RY, Lampe PD, Yan M, Markowitz SD, Bigler J, Lampe JW, Potter JD.

BMC Med Genet. 2015 Mar 24;16:18. doi: 10.1186/s12881-015-0161-6.

11.

Dynamics of the cytotoxic T cell response to a model of acute viral infection.

DeWitt WS, Emerson RO, Lindau P, Vignali M, Snyder TM, Desmarais C, Sanders C, Utsugi H, Warren EH, McElrath J, Makar KW, Wald A, Robins HS.

J Virol. 2015 Apr;89(8):4517-26. doi: 10.1128/JVI.03474-14. Epub 2015 Feb 4.

12.

Blood lipids and colorectal polyps: testing an etiologic hypothesis using phenotypic measurements and Mendelian randomization.

Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Potter JD, Upton MP, Zhu LC, Rosenfeld ME, Schwartz SM, Rutter CM.

Cancer Causes Control. 2015 Mar;26(3):467-73. doi: 10.1007/s10552-015-0526-3. Epub 2015 Jan 25.

13.

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.

Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson AB 3rd, Mayer RJ, Cripps CM, Danenberg K, Makar KW, Zhang W, Benedetti JK, Lenz HJ.

Clin Cancer Res. 2015 Apr 1;21(7):1583-90. doi: 10.1158/1078-0432.CCR-14-0857. Epub 2015 Jan 14.

14.

Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.

Flote VG, Furberg AS, McTiernan A, Frydenberg H, Ursin G, Iversen A, Lofteroed T, Ellison PT, Wist EA, Egeland T, Wilsgaard T, Makar KW, Chang-Claude J, Thune I.

Breast Cancer Res. 2014 Dec 19;16(6):499. doi: 10.1186/s13058-014-0499-2.

15.

Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer.

Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM, Habermann N.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2632-7. doi: 10.1158/1055-9965.EPI-14-0556.

16.

Rare circulating microRNAs as biomarkers of colorectal neoplasia.

Adams SV, Newcomb PA, Burnett-Hartman AN, Wurscher MA, Mandelson M, Upton MP, Zhu LC, Potter JD, Makar KW.

PLoS One. 2014 Oct 6;9(10):e108668. doi: 10.1371/journal.pone.0108668. eCollection 2014.

17.

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.

Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, Galipeau PC, Shaheen NJ, Hardie LJ, Romero Y, Bernstein L, Gammon MD, Casson AG, Bird NC, Risch HA, Ye W, Liu G, Corley DA, Blount PL, Fitzgerald RC, Whiteman DC, Wu AH, Reid BJ, Vaughan TL.

Carcinogenesis. 2014 Dec;35(12):2740-7. doi: 10.1093/carcin/bgu207. Epub 2014 Oct 3.

18.

Nightshift work and genome-wide DNA methylation.

Bhatti P, Zhang Y, Song X, Makar KW, Sather CL, Kelsey KT, Houseman EA, Wang P.

Chronobiol Int. 2015 Feb;32(1):103-12. doi: 10.3109/07420528.2014.956362. Epub 2014 Sep 4.

PMID:
25187986
19.

No effect of caloric restriction or exercise on radiation repair capacity.

Habermann N, Makar KW, Abbenhardt C, Xiao L, Wang CY, Utsugi HK, Alfano CM, Campbell KL, Duggan C, Foster-Schubert KE, Mason CE, Imayama I, Blackburn GL, Potter JD, McTiernan A, Ulrich CM.

Med Sci Sports Exerc. 2015 May;47(5):896-904. doi: 10.1249/MSS.0000000000000480.

20.

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).

Ulrich CM, Rankin C, Toriola AT, Makar KW, Altug-Teber Ö, Benedetti JK, Holmes RS, Smalley SR, Blanke CD, Lenz HJ.

Cancer. 2014 Nov 1;120(21):3329-3337. doi: 10.1002/cncr.28830. Epub 2014 Jul 15.

21.

Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.

Resler AJ, Makar KW, Heath L, Whitton J, Potter JD, Poole EM, Habermann N, Scherer D, Duggan D, Wang H, Lindor NM, Passarelli MN, Baron JA, Newcomb PA, Le Marchand L, Ulrich CM.

Carcinogenesis. 2014 Sep;35(9):2121-6. doi: 10.1093/carcin/bgu119. Epub 2014 Jun 7.

22.

Variation in the association between colorectal cancer susceptibility loci and colorectal polyps by polyp type.

Burnett-Hartman AN, Newcomb PA, Hutter CM, Peters U, Passarelli MN, Schwartz MR, Upton MP, Zhu LC, Potter JD, Makar KW.

Am J Epidemiol. 2014 Jul 15;180(2):223-32. doi: 10.1093/aje/kwu114. Epub 2014 May 29.

23.

Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.

Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM.

Gastroenterology. 2014 Aug;147(2):418-29.e8. doi: 10.1053/j.gastro.2014.04.039. Epub 2014 Apr 30.

24.

Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.

Scherer D, Koepl LM, Poole EM, Balavarca Y, Xiao L, Baron JA, Hsu L, Coghill AE, Campbell PT, Kleinstein SE, Figueiredo JC, Lampe JW, Buck K, Potter JD, Kulmacz RJ, Jenkins MA, Hopper JL, Win AK, Newcomb PA, Ulrich CM, Makar KW.

Genes Chromosomes Cancer. 2014 Jul;53(7):568-78. doi: 10.1002/gcc.22167. Epub 2014 Mar 28.

25.

Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women.

Abbenhardt C, Miller JW, Song X, Brown EC, Cheng TY, Wener MH, Zheng Y, Toriola AT, Neuhouser ML, Beresford SA, Makar KW, Bailey LB, Maneval DR, Green R, Manson JE, Van Horn L, Ulrich CM.

J Nutr. 2014 May;144(5):714-21. doi: 10.3945/jn.113.183970. Epub 2014 Mar 19.

26.

Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

Abbenhardt C, Poole EM, Kulmacz RJ, Xiao L, Curtin K, Galbraith RL, Duggan D, Hsu L, Makar KW, Caan BJ, Koepl L, Owen RW, Scherer D, Carlson CS; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and CCFR, Potter JD, Slattery ML, Ulrich CM.

Int J Mol Epidemiol Genet. 2013 Sep 12;4(3):140-9. eCollection 2013.

27.

Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.

Wang H, Taverna D, Stram DO, Fortini BK, Cheng I, Wilkens LR, Burnett T, Makar KW, Lindor NM, Hopper JL, Gallinger S, Baron JA, Haile R, Kolonel LN, Henderson BE, Newcomb PA, Casey G, Duggan D, Ulrich CM, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2094-101. doi: 10.1158/1055-9965.EPI-13-0694. Epub 2013 Sep 17.

28.

COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.

Makar KW, Poole EM, Resler AJ, Seufert B, Curtin K, Kleinstein SE, Duggan D, Kulmacz RJ, Hsu L, Whitton J, Carlson CS, Rimorin CF, Caan BJ, Baron JA, Potter JD, Slattery ML, Ulrich CM.

Cancer Causes Control. 2013 Dec;24(12):2059-75. doi: 10.1007/s10552-013-0282-1.

29.

No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.

Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Phipps AI, David SP, Hsu L, Harrison TA, Hutter CM, Duggan DJ, White E, Chan AT, Peters U.

Menopause. 2014 Apr;21(4):415-20. doi: 10.1097/GME.0b013e31829e498d.

30.

Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.

Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM.

Pharmacogenet Genomics. 2013 Aug;23(8):428-437. doi: 10.1097/FPC.0b013e3283631784.

31.

Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women.

Phipps AI, Makar KW, Newcomb PA.

Int J Colorectal Dis. 2013 Dec;28(12):1637-42. doi: 10.1007/s00384-013-1715-8. Epub 2013 Jun 1.

32.

Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.

Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, Grady WM, Zhu LC, Upton MP, Makar KW.

Cancer Res. 2013 May 1;73(9):2863-72. doi: 10.1158/0008-5472.CAN-12-3462. Epub 2013 Mar 28.

33.

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers.

Phipps AI, Buchanan DD, Makar KW, Win AK, Baron JA, Lindor NM, Potter JD, Newcomb PA.

Br J Cancer. 2013 Apr 30;108(8):1757-64. doi: 10.1038/bjc.2013.118. Epub 2013 Mar 19.

34.

Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.

Kleinstein SE, Heath L, Makar KW, Poole EM, Seufert BL, Slattery ML, Xiao L, Duggan DJ, Hsu L, Curtin K, Koepl L, Muehling J, Taverna D, Caan BJ, Carlson CS, Potter JD, Ulrich CM.

Genes Chromosomes Cancer. 2013 May;52(5):437-49. doi: 10.1002/gcc.22042. Epub 2013 Feb 12.

35.

Gene expression changes in adipose tissue with diet- and/or exercise-induced weight loss.

Campbell KL, Foster-Schubert KE, Makar KW, Kratz M, Hagman D, Schur EA, Habermann N, Horton M, Abbenhardt C, Kuan LY, Xiao L, Davison J, Morgan M, Wang CY, Duggan C, McTiernan A, Ulrich CM.

Cancer Prev Res (Phila). 2013 Mar;6(3):217-31. doi: 10.1158/1940-6207.CAPR-12-0212. Epub 2013 Jan 22.

36.

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.

Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T, Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia WH, Kolonel LN, Kooperberg C, Küry S, Lacroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar KW, Matsuo K, Newcomb PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse SA, Schoen RE, Seminara D, Shrubsole M, Shu XO, Slattery ML, Taverna D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng YX, Zhang B, Zheng W, Hsu L; Colon Cancer Family Registry and the Genetics and Epidemiology of Colorectal Cancer Consortium.

Gastroenterology. 2013 Apr;144(4):799-807.e24. doi: 10.1053/j.gastro.2012.12.020. Epub 2012 Dec 22. Review.

37.

Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.

Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA.

Cancer Res. 2013 Jan 15;73(2):767-75. doi: 10.1158/0008-5472.CAN-12-2484. Epub 2012 Nov 13.

38.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM.

Cancer Causes Control. 2013 Jan;24(1):47-54. doi: 10.1007/s10552-012-0088-6. Epub 2012 Oct 19.

39.

IκBKβ and NFκB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry.

Seufert BL, Poole EM, Whitton J, Xiao L, Makar KW, Campbell PT, Kulmacz RJ, Baron JA, Newcomb PA, Slattery ML, Potter JD, Ulrich CM.

Carcinogenesis. 2013 Jan;34(1):79-85. doi: 10.1093/carcin/bgs296. Epub 2012 Sep 22.

40.

Characterizing and quantifying leukocyte populations in human adipose tissue: impact of enzymatic tissue processing.

Hagman DK, Kuzma JN, Larson I, Foster-Schubert KE, Kuan LY, Cignarella A, Geamanu E, Makar KW, Gottlieb JR, Kratz M.

J Immunol Methods. 2012 Dec 14;386(1-2):50-9. doi: 10.1016/j.jim.2012.08.018. Epub 2012 Sep 10.

41.

BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics.

Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1792-8. doi: 10.1158/1055-9965.EPI-12-0674. Epub 2012 Aug 16.

42.

PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer.

Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, Caan B, Kulmacz R, Whitton J, Galbraith R, Potter JD, Slattery ML.

Genes Nutr. 2013 Jan;8(1):115-26. doi: 10.1007/s12263-012-0302-x. Epub 2012 Jun 8.

43.

Genetic polymorphism CYP17 rs2486758 and metabolic risk factors predict daily salivary 17β-estradiol concentration in healthy premenopausal Norwegian women. The EBBA-I study.

Iversen A, Thune I, McTiernan A, Makar KW, Wilsgaard T, Ellison PT, Jasienska G, Flote V, Poole EM, Furberg AS.

J Clin Endocrinol Metab. 2012 May;97(5):E852-7. doi: 10.1210/jc.2011-2577. Epub 2012 Mar 14.

PMID:
22419734
44.

Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.

Haug U, Poole EM, Xiao L, Curtin K, Duggan D, Hsu L, Makar KW, Peters U, Kulmacz RJ, Potter JD, Koepl L, Caan BJ, Slattery ML, Ulrich CM.

Genes Chromosomes Cancer. 2012 Jun;51(6):598-605. doi: 10.1002/gcc.21946. Epub 2012 Feb 27.

45.

Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.

Poole EM, Curtin K, Hsu L, Kulmacz RJ, Duggan DJ, Makar KW, Xiao L, Carlson CS, Slattery ML, Caan BJ, Potter JD, Ulrich CM.

Int J Mol Epidemiol Genet. 2011;2(4):300-15. Epub 2011 Dec 3.

46.

Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer.

Poole EM, Curtin K, Hsu L, Duggan DJ, Makar KW, Xiao L, Carlson CS, Caan BJ, Potter JD, Slattery ML, Ulrich CM.

Cancer Epidemiol. 2012 Apr;36(2):e104-10. doi: 10.1016/j.canep.2011.11.001. Epub 2011 Dec 6.

47.

Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo.

Raccor BS, Claessens AJ, Dinh JC, Park JR, Hawkins DS, Thomas SS, Makar KW, McCune JS, Totah RA.

Drug Metab Dispos. 2012 Jan;40(1):54-63. doi: 10.1124/dmd.111.039347. Epub 2011 Oct 5.

48.

Genetic variation in inflammatory pathways is related to colorectal cancer survival.

Coghill AE, Newcomb PA, Poole EM, Hutter CM, Makar KW, Duggan D, Potter JD, Ulrich CM.

Clin Cancer Res. 2011 Nov 15;17(22):7139-47. doi: 10.1158/1078-0432.CCR-11-1134. Epub 2011 Oct 5.

49.

Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women.

Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA.

Genes Chromosomes Cancer. 2011 Nov;50(11):875-86. doi: 10.1002/gcc.20913. Epub 2011 Aug 24.

50.

No evidence for human papillomavirus in the etiology of colorectal polyps.

Burnett-Hartman AN, Newcomb PA, Mandelson MT, Galloway DA, Madeleine MM, Wurscher MA, Carter JJ, Makar KW, Potter JD, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2288-97. doi: 10.1158/1055-9965.EPI-11-0450. Epub 2011 Aug 4.

Supplemental Content

Loading ...
Support Center